65042 Federal Register / Vol. 72, No. 222 / Monday, November 19, 2007 / Notices 

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1

21 CFR Part Form No. of 

Respondents 

Annual Frequency 

per Response 

Total Annual 

Responses 

Hours per 

Response Total Hours 

710 FDA 2511 135 1 135 0.2 27 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

FDA bases its estimate on its review 

of the registrations received over the 

past 3 fiscal years. The total annual 

responses (averaged over fiscal years 

2004 through 2006) is 9 times the 

previous total reported in 2004 (for 

fiscal years 2000 through 2003) due to 

increased participation by cosmetic 

companies, because of a renewed 

industry commitment to the program, 

and implementation of the online 

registration system on December 1, 

2005. Due to the ease of online 

registration, FDA estimates that the 

hours per response have declined from 

0.4 hours to 0.2 hours. Thus, the total 

estimated hour burden for this 

information collection is 27 hours, 

which is 4.5 times the previous level 

reported in 2004. 

Dated: November 13, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E7–22588 Filed 11–16–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2006F–0058] 

ARCH Chemicals, Inc.; Withdrawal of 

Food Additive Petition FAP 6B4764 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

withdrawal, without prejudice to a 

future filing, of a food additive petition 

(FAP 6B4764) proposing that the food 

additive regulations be amended to 

provide for the safe use of poly 

(iminoimidocarbonyliminoimidocarbon

yliminohexamethylene) hydrochloride 

(CAS Reg No. 32289–58–0) as an 

antimicrobial agent in the manufacture 

of food-contact paper and paperboard. 

FOR FURTHER INFORMATION CONTACT: 

Elizabeth S. Furukawa, Center for Food 

Safety and Applied Nutrition (HFS–

275), Food and Drug Administration, 

5100 Paint Branch Pkwy., College Park, 

MD 20740–3835, 301–436–1216, e-mail: 

Elizabeth.Furukawa@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In a notice 

published in the Federal Register of 

February 15, 2006 (71 FR 7975), FDA 

announced that a food additive petition 

(FAP 6B4764) had been filed by ARCH 

Chemicals, Inc., 1955 Lake Park Dr., 

suite 100, Smyrna, GA 30080. The 

petition proposed to amend the food 

additive regulations in 21 CFR 176.170 

Components of paper and paperboard 

in contact with aqueous and fatty foods 

and 21 CFR 176.180 Components of 

paper and paperboard in contact with 

dry food to provide for the safe use of 

poly (iminoimidocarbonyliminoimido

carbonyliminohexamethylene) 

hydrochloride (CAS Reg. No. 32289–58–

0) as an antimicrobial agent in the 

manufacture of food-contact paper and 

paperboard. ARCH Chemicals, Inc., has 

now withdrawn the petition without 

prejudice to a future filing (21 CFR 

171.7). 

Dated: November 9, 2007. 

Laura M. Tarantino, 

Director, Office of Food Additive Safety, 

Center for Food Safety and Applied Nutrition. 

[FR Doc. E7–22536 Filed 11–16–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[FDA 225–07–7001] 

Memorandum of Understanding 

Between the Food and Drug 

Administration and the Association of 

American Feed Control Officials 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between FDA and 

the Association of American Feed 

Control Officials (AAFCO). The purpose 

of this MOU is to facilitate FDA’s 

collaboration with AAFCO in the 

AAFCO New and Modified Ingredient 

Definition Process by clarifying the 

responsibilities of FDA and AAFCO in 

defining feed ingredients, in providing 

mechanisms for resolving disputes that 

may arise, and in providing mechanisms 

for modifying the ingredient definition 

process when required. 

DATES: The agreement became effective 

August 30, 2007. 

FOR FURTHER INFORMATION CONTACT: 

Sharon Benz, Division of Animal Feeds 

(HFV–220), Center for Veterinary 

Medicine, Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–453–6864. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 

which states that all written agreements 

and MOUs between FDA and others 

shall be published in the Federal 

Register, the agency is publishing notice 

of this MOU. 

Dated: November 12, 2007. 

Randall W. Lutter, 

Deputy Commissioner for Policy. 

BILLING CODE 4160–01–S 


rwilkins on PROD1PC63 with NOTICES
Federal Register / Vol. 72, No. 222 / Monday, November 19, 2007 / Notices 65043 


rwilkins on PROD1PC63 with NOTICESEN19NO07.016</GPH>
65044 Federal Register / Vol. 72, No. 222 / Monday, November 19, 2007 / Notices 


rwilkins on PROD1PC63 with NOTICESEN19NO07.017</GPH>
Federal Register / Vol. 72, No. 222 / Monday, November 19, 2007 / Notices 65045 


rwilkins on PROD1PC63 with NOTICESEN19NO07.018</GPH>
65046 Federal Register / Vol. 72, No. 222 / Monday, November 19, 2007 / Notices 

[FR Doc. 07–5748 Filed 11–16–07; 8:45 am] 

BILLING CODE 4160–01–C 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2007D–0449] 

Draft Guidance for Food and Drug 

Administration Advisory Committee 

Members and Food and Drug 

Administration Staff: Voting 

Procedures for Advisory Committee 

Meetings; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of a draft guidance 

document for FDA advisory committee 

members and FDA staff entitled, 

‘‘Voting Procedures for Advisory 

Committee Meetings.’’ This draft 

document is intended to provide 

guidance on advisory committee voting 

procedures that can be used for the 

voting process when votes are taken 

during advisory committee meetings. It 

does not to define when votes should be 

taken. 

DATES: Although you can comment on 

any guidance at any time (see 21 CFR 

10.115(g)(5)), to ensure that the agency 

considers your comment on this draft 

guidance before it begins work on the 

final version of the guidance, submit 

written or electronic comment on the 

draft guidance by January 18, 2007. 

ADDRESSES: Submit written requests for 

single copies of the guidance to the 

Office of Policy (HF–11), Office of the 

Commissioner, Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857. Send one selfaddressed adhesive label to assist that 

office in processing your requests. 

Submit phone requests to 800–835–4709 

or 301–827–1800. Submit written 

comments on the guidance to the 

Division of Dockets Management (HFA–

305), Food and Drug Administration, 

5630 Fishers Lane, rm. 1061, Rockville, 

MD 20852. Submit electronic comments 

to http://www.fda.gov/dockets/ 

ecomments or http:// 

www.regulations.gov. See the 

SUPPLEMENTARY INFORMATION section for 

electronic access to the guidance 

document. 

FOR FURTHER INFORMATION CONTACT: Jill 

Hartzler Warner, Office of Policy, 

Planning, and Preparedness (HF–11), 

Food and Drug Administration, 5600 

Fishers Lane, Rockville, MD 20857, 

301–827–3370. 


rwilkins on PROD1PC63 with NOTICESEN19NO07.019</GPH>